PerkinElmer, Inc. Names Prahlad Singh as President and Chief Operating Officer, Effective January 1, 2019
December 10, 2018 at 08:00 am
Share
PerkinElmer, Inc. announced that its board of directors has named Prahlad Singh president and chief operating officer, effective January 1, 2019. In his expanded position, Dr. Singh will have responsibility for both the Discovery and Analytical Solutions (DAS) and Diagnostics operating divisions of the Company. This change is being made to better facilitate synergies across the businesses to identify incremental growth opportunities, create operating efficiencies, and most importantly, accelerate the pace of innovation across the Company. Dr. Singh, along with the leaders of the Company’s corporate functions, will continue to report to Robert F. Friel, PerkinElmer’s chairman and chief executive officer. Dr. Singh joined PerkinElmer in 2014 as president of the Diagnostics business. He was elected an officer of PerkinElmer in 2016 and executive vice president in March 2018. Dr. Singh served as general manager of GE Healthcare’s Women’s Health Business, responsible for the mammography and bone densitometry businesses.
Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows:
- medical diagnosis equipment (61%);
- analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc.
Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).
REVVITY, INC. 
